“When I first came to North Carolina in 1994, the only drugs for diabetes were human and animal insulin, glyburide, glipizide; meters took over a minute and needed a hanging drop of blood (enough to drip off the finger); pumps were rudimentary; diabetes educators and strips were not paid for . . . . UNC’s Diabetes Center has made a major difference in all of this.” – John Buse, MD, PhD, Chief Division of Endocrinology, Director of the UNC Diabetes Care Center.
Research plays a central role at the UNC Diabetes Care Center which has allowed us to stay at the forefront of diabetes treatment. Working with National Institutes of Health, members of the healthcare industry and research foundations, we have conducted more than 200 research studies over the last 15 years, including the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Because of the commitment of research participants, significant advances have been made in diabetes technology and treatments. The medications, blood glucose meters, insulin pumps, continuous glucose monitoring devices, and treatment options used today are only possible because of people who participated in research studies.